Investor FAQ
TRXADE HEALTH, INC (NASDAQ: MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving a total of 12,700+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services.
TRxADE Group, Inc. trades under the Nasdaq ticker symbol MEDS
CUSIP number: 89846A207
The company’s common stock can be purchased through any registered broker-dealer.
The company does not declare dividends on shares of its common stock at this time.
As of October 22, 2021, there were 8,166,457 shares of common stock issued and outstanding.
The company does not have a direct stock purchase plan at this time.
December 31st.
Approximately 40
Action Stock Transfer Corp.
2469 E Fort Union Blvd. Suite 214
Salt Lake City UT 84121
Voice: 801-274-1088
Fax: 801-274-1099
MaloneBailey, LLP
9801 Westheimer Road Suite 100
Houston, TX, 77042
Tel: (713) 343-4286
Fax: (949) 428-0280
TRxADE Group, Inc.
2420 Brunello Trace
Lutz, Florida 33558
Tel: (800) 261-0281
Fax: (800) 265-6932
www.trxadegroup.com